The regulation of endogenous PHLDA1 expression in HER2+ breast cancer cells is therefore likely to be controlled largely by PKC/MAPK signalling, consistent with observations in immortalised human mammary epithelial cells [13] and MEK1 mutant cancers [15]. This evidence concerns the gene ERBB2 and breast cancer.